The REDEMPTION-3 eTrial is now open to patients with Genotypes 1 4 5 and 6.  REDEMPTION-3 is using tablets containing generic Harvoni ® (Sofosbuvir 400 mg / Ledipasvir 90 mg) sourced from a variety of reputable manufacturers such as Cipla, Incepta, Hetero, Natco, Beacon and Julphar. There is no placebo, and the trial is open … Continue reading REDEMPTION-3